Transcatheter Embolization and Occlusion Devices Market is Projected to Reach US$ 4.5 Billion by 2024
New York, July 10, 2018: The Transcatheter Embolization and Occlusion Devices market is expected to exceed more than US$ 4.5 Billion by 2024; Growing at a CAGR of more than 7.5% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Transcatheter Embolization and Occlusion Devices Market with the reasons given for variations in the growth of the industry in certain regions.
Transcatheter embolization is a method of insertion synthetic material or medication called embolic agent into blood vessel during catheter to block the blood flow in the direction of a specific area of the body. Embolization is a very efficient method to prevent anomalous bleeding and is simply enveloping as compared to open surgery. The transcatheter embolization and occlusion devices market have observed physically powerful development in the past few years because of the increasing focus on improvement, resulting in superior product approvals and product launches around the word. The market is also differentiating by considerable research and progress leading to numerous technological innovations.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include St. Jude Medical, Inc., Abbott Laboratories,Medtronic plc, BTG plc, Boston Scientific Corporation, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Browse Full Report: https://www.marketresearchengine.com/reportdetails/transcatheter-embolization-and-occlusion-devices-market
Market Research Engine has published a
new report titled as “Transcatheter
Embolization and Occlusion Devices Market By Product Type (Embolization Coils,
Embolization Particles, Coiling Assist Devices, Flow Diverter Devices, Liquid
Embolics, and Accessories); By Application (Peripheral Vascular Disease, Neurology,
Oncology, Urology); By End-users - Global Industry Analysis and Forecast 2016 -
2024”.
Table of Contents
1 INTRODUCTION
2. Assumptions and Research Methodology
3. Executive Summary: Transcatheter Embolization and
Occlusion Devices Market
4. Market Overview
5. Transcatheter Embolization and Occlusion Devices Market
Analysis and Forecast, by Product
6. Transcatheter Embolization and Occlusion Devices Market
Analysis and Forecasts, by Application, 2016–2024
7. Transcatheter Embolization and Occlusion Devices Market
Analysis and Forecasts, by End-user, 2016–2024
8. Transcatheter Embolization and Occlusion Devices Market
Analysis and Forecasts, by Region, 2016–2024
9. North America Transcatheter Embolization and Occlusion
Devices Market Analysis and Forecast, 2014–2024
10. Europe Transcatheter Embolization and Occlusion Devices
Market Analysis and Forecast
11. Asia Pacific Transcatheter Embolization and Occlusion
Devices Market Analysis and Forecast, 2016–2024
12. Latin America Transcatheter Embolization and Occlusion
Devices Market Analysis and Forecast, 2016–2024
13. Middle East & Africa Transcatheter Embolization and
Occlusion Devices Market Analysis and Forecast, 2016–2024
14. Competition Landscape
14.1. Market
Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share
Analysis, by Company (2015)
14.3. Company
Profiles (Details - Overview, Financials, Recent Developments, Strategy)
14.3.1.
Abbott Laboratories
14.3.2.
Boston Scientific Corporation
14.3.3. BTG International Ltd
14.3.4.
Cook Medical
14.3.5.
Edward Lifesciences
14.3.6.
Johnson & Johnson
14.3.7.
Medtronic, plc
14.3.8.
Merit Medical Systems, Inc.
14.3.9.
Penumbra, Inc.
14.3.10.
Pfizer, Inc.
14.3.11.
Sirtex Medical Limited
14.3.12.
St. Jude Medical, Inc.
14.3.13.
Stryker Corporation
14.3.14.
Terumo Corporation
Request Sample Report from here:
https://www.marketresearchengine.com/reportdetails/transcatheter-embolization-and-occlusion-devices-market
By Application Analysis this market is segmented on the basis of Peripheral Vascular Disease, Neurology, Oncology, Urology and Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
The restraining factors of Transcatheter Embolization and Occlusion devices market are as follows:
• High rate of the products.
• Need of skilled professionals
This report provides:
1) An overview of the global market for transcatheter embolization and occlusion devices and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for transcatheter embolization and occlusion devices.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Transcatheter Embolization & Occlusion devices market are as follows:
• Increasing prevalence of cancer
• Rising approval of minimally invasive surgeries
Reasons to Buy this Report:
1) Obtain the most up to date information available on all transcatheter embolization and occlusion devices.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of transcatheter embolization and occlusion devices data.
4) Assess your competitor’s refining portfolio and its evolution.
Media Contact
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com
Comments
Post a Comment